Home

ImmunoPrecise Antibodies Ltd. - Common Stock (IPA)

0.3400
+0.00 (0.00%)
NASDAQ · Last Trade: Apr 4th, 9:37 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Competitors to ImmunoPrecise Antibodies Ltd. - Common Stock (IPA)

Abcam Plc

Abcam Plc has established itself as a leader in providing high-quality antibodies and related products for research and diagnostic applications. They compete with ImmunoPrecise Antibodies Ltd. by offering a broad catalog of over one million products that cater to various scientific needs. Abcam's extensive customer base and strong brand recognition in the life sciences sector provide them with a competitive advantage, particularly in online sales and global reach.

Bio-Rad Laboratories, Inc. BIO +0.00

Bio-Rad Laboratories competes with ImmunoPrecise Antibodies by providing a comprehensive range of life sciences research and clinical diagnostic products, including a significant offering of antibodies. Bio-Rad’s reputation for quality and innovation, along with strong customer relationships built over decades, gives them a competitive edge. However, ImmunoPrecise may leverage its specialized services in custom antibody development to carve out a niche within the broader market.

Miltenyi Biotec

Miltenyi Biotec specializes in products and services for cell biology and immunology research, including antibodies and related technologies. They compete by focusing on innovative product development and solutions aimed at advancing research in stem cells and cell therapy. ImmunoPrecise Antibodies and Miltenyi Biotec might overlap in some markets, but Miltenyi's strong research background and extensive technology offerings may give them a competitive advantage in certain areas, particularly in cell therapies.

SeraCare Life Sciences, Inc.

SeraCare Life Sciences provides products and services related to molecular biology and diagnostics, competing indirectly with ImmunoPrecise Antibodies in the field of antibodies and assays. While SeraCare has a strong focus on quality control and standardized materials, ImmunoPrecise may focus on rapid development and custom antibody solutions as their primary competitive strategy. SeraCare's established position in patient safety and compliance gives them an advantage in the diagnostics market, although both companies serve unique niches.

Thermo Fisher Scientific Inc. TMO +0.00

Thermo Fisher Scientific is a prominent player in the life sciences tools market, offering a wide range of products including antibodies, reagents, and other research solutions. Their massive scale, diverse product portfolio, and robust distribution channels allow them to dominate the market, making it challenging for ImmunoPrecise Antibodies to compete on the same level. However, ImmunoPrecise might focus on niche applications and custom antibody development to differentiate itself in specific research segments.